Literature DB >> 24634283

Cancer cachexia update in head and neck cancer: Pathophysiology and treatment.

Marion E Couch1, Kim Dittus2, Michael J Toth3, Monte S Willis4, Denis C Guttridge5, Jonathan R George6, Eric Y Chang7, Christine G Gourin8, Hirak Der-Torossian1.   

Abstract

The pathophysiology of cancer cachexia remains complex. A comprehensive literature search was performed up to April 2013 using PubMed, the Cochrane Library, Cumulative Index to Nursing and Allied Health Literature, and the Google search engine. In this review, we focus on the different mediators of impaired anabolism and upregulated catabolism that alter the skeletal muscle homeostasis resulting in the wasting of cancer cachexia. We present recent evidence of targeted treatment modalities from clinical trials along with their potential mechanisms of action. We also report on the most current evidence from randomized clinical trials using multimodal treatments in patients with cancer cachexia, but also the evidence from head and neck cancer-specific trials. A more complete understanding of the pathophysiology of the syndrome may lead to more effective targeted therapies and improved outcomes for patients.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  cancer cachexia and anorexia; clinical trials; head and neck cancer; multimodal treatment; pathophysiology

Mesh:

Year:  2015        PMID: 24634283     DOI: 10.1002/hed.23696

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

Review 1.  Malnutrition and cachexia in patients with head and neck cancer treated with (chemo)radiotherapy.

Authors:  Mojca Gorenc; Nada Rotovnik Kozjek; Primož Strojan
Journal:  Rep Pract Oncol Radiother       Date:  2015-03-29

2.  Poor dental condition is a factor of imbalance of the nutritional status at the outset of management of head and neck cancer.

Authors:  Laurent Devoize; Camille Dumas; Céline Lambert; Mohamed El Yagoubi; Thierry Mom; Nicolas Farigon; Laurent Gilain; Yves Boirie; Nicolas Saroul
Journal:  Clin Oral Investig       Date:  2021-08-20       Impact factor: 3.606

3.  Post-translationally modified muscle-specific ubiquitin ligases as circulating biomarkers in experimental cancer cachexia.

Authors:  Roberto Mota; Jessica E Rodríguez; Andrea Bonetto; Thomas M O'Connell; Scott A Asher; Traci L Parry; Pamela Lockyer; Christopher R McCudden; Marion E Couch; Monte S Willis
Journal:  Am J Cancer Res       Date:  2017-09-01       Impact factor: 6.166

4.  The TLR7/8/9 Antagonist IMO-8503 Inhibits Cancer-Induced Cachexia.

Authors:  Federica Calore; Priya Londhe; Paolo Fadda; Giovanni Nigita; Lucia Casadei; Gioacchino Paolo Marceca; Matteo Fassan; Francesca Lovat; Pierluigi Gasparini; Lara Rizzotto; Nicola Zanesi; Devine Jackson; Svasti Mehta; Patrick Nana-Sinkam; Deepa Sampath; Raphael E Pollock; Denis C Guttridge; Carlo M Croce
Journal:  Cancer Res       Date:  2018-09-12       Impact factor: 12.701

Review 5.  A review of weight loss and sarcopenia in patients with head and neck cancer treated with chemoradiation.

Authors:  Shrujal S Baxi; Emily Schwitzer; Lee W Jones
Journal:  Cancers Head Neck       Date:  2016-08-17

Review 6.  Managing Cachexia in Head and Neck Cancer: a Systematic Scoping Review.

Authors:  Antti A Mäkitie; Rasheed Omobolaji Alabi; Helena Orell; Omar Youssef; Alhadi Almangush; Akihiro Homma; Robert P Takes; Fernando López; Remco de Bree; Juan P Rodrigo; Alfio Ferlito
Journal:  Adv Ther       Date:  2022-02-27       Impact factor: 3.845

7.  Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy.

Authors:  Yu-Ching Lin; Cheng-Hsu Wang; Hang Huong Ling; Yi-Ping Pan; Pei-Hung Chang; Wen-Chi Chou; Fang-Ping Chen; Kun-Yun Yeh
Journal:  Biomedicines       Date:  2022-02-06

8.  A Single Axial Slice of the Sternocleidomastoids and Paravertebral Muscles Associated with Worse Local Progression-Free Survival and Severe Toxicity in Sarcopenic Head and Neck Cancer Patients Undergoing Radiotherapy.

Authors:  William Jin; Benjamin Rich; Raphael Yechieli; Laura Freedman; Michael A Samuels; Matthew Abramowitz; Ruben Carmona; Stuart E Samuels
Journal:  Cureus       Date:  2022-02-21

9.  Pretreatment Glasgow Prognostic Score Correlated with Serum Histidine Level and Three-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma and Optimal Performance Status.

Authors:  Kun-Yun Yeh; Chao-Hung Wang; Hang Huong Ling; Chia-Lin Peng; Zih-Syuan Chen; Simon Hsia
Journal:  Nutrients       Date:  2022-08-24       Impact factor: 6.706

10.  Determining Malnutrition Assessment Criteria to Predict One-Year Mortality for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy.

Authors:  Hang Huong Ling; Kun-Yun Yeh; Shu-Hang Ng; Cheng-Hsu Wang; Chien-Hong Lai; Tsung-Han Wu; Pei-Hung Chang; Wen-Chi Chou; Fang-Ping Chen; Yu-Ching Lin
Journal:  Nutrients       Date:  2020-03-20       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.